Research Article
sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective
Figure 1
Patient management diagram for the no-testing strategy (based on standard of care) and assumed hospitalization rates according to the PROGNOSIS study. Grey shading indicates confirmed cases of preeclampsia. PlGF: placental growth factor; sFlt-1: soluble fms-like tyrosine kinase-1; SOC: standard of care.